Product
Olorofim
2 clinical trials
2 indications
Indication
Invasive AspergillosisIndication
Renal ImpairmentClinical trial
Phase III, Adjudicator-blinded, Randomised Study to Evaluate Efficacy and Safety of Treatment With Olorofim Versus Treatment With AmBisome® Followed by Standard of Care in Patients With Invasive Fungal Disease Caused by Aspergillus SpeciesStatus: Recruiting, Estimated PCD: 2024-09-14
Clinical trial
A Phase I, Single-dose, Parallel Group Study to Assess the Pharmacokinetics of Olorofim in Subjects With Renal ImpairmentStatus: Completed, Estimated PCD: 2022-12-13